Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 10,381–10,400 of 17,974 drug recalls

Drug Recall Terminated Historical recordClass II

Option Systems Antibacterial Foaming Hand Wash, 0.3% P.C.M.X., 8 fl oz and 18 fl oz. bottles and 500, mL 800 mL, and 1000 mL pouches, ALSO labeled as STYLE Antibacterial Hand Soap, Inopak Ltd Ringwood, NJ --- NDC 5031-431-02

by Inopak Ltd

Reason
GMP Deviations; potential bacterial contamination may have been introduced to products through a contaminated diaphragm pump
Recall initiated
August 23, 2017
Reported by FDA
October 11, 2017
Distribution
nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Deferoxamine Mesylate for injection, USP, Single-use Vial, 500 mg/vial, 10 mL vial. Intravenous, Intramuscular, Subcutaneous Use, Rx Only, Hospira, Inc., Lake Forest IL USA, NDC 0406-2336-10.

by Pfizer Inc.

Reason
CGMP Deviations: Firm failed to control impurity for color change at the API stage.
Recall initiated
July 12, 2017
Reported by FDA
October 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Ampicillin for Injection, USP, 500 mg per vial, single vial (NDC 0781-3407-78) packaged in 10-count shrink wrap packs (NDC 0781-3407-95), Rx only, Manufactured in Austria by Sandoz GmbH or Sandoz Inc., Princeton, NJ 08540.

by Sandoz Inc

Reason
Labeling: Missing Label: customer complaint that some vials of ampicillin within the shrink wrap pack are missing labels.
Recall initiated
September 25, 2017
Reported by FDA
October 4, 2017
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Acarbose Tablets, 25 mg, 100-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 16252-523-01.

by Teva Pharmaceuticals USA

Reason
Labeling: Incorrect or Missing Lot and/or Exp Date: An incorrect expiration date of July 2018 is printed on the product labeling rather than the correct expiration date of July 2017.
Recall initiated
September 5, 2017
Reported by FDA
October 4, 2017
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Sterile Water for Injection, USP Single Dose 100 mL vials, Rx only, Manufactured by Hospira, Inc., Lake Forest, IL 60045 USA for Genentech, Inc., South San Francisco, CA 94080-4990. NDC 50242-901-24

by Pfizer Inc.

Reason
Non-Sterility: cracked or chipped glass at the neck of Sterile Water for Injection vials.
Recall initiated
September 1, 2017
Reported by FDA
October 4, 2017
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Ketorolac Trom 30 mg/mL Injection, packaged in a) 1 mL vials, NDC 61786-0741-01 (Orig: 00548-9021-00), Ref: 33631 and b) 10 x 1 mL vials per tray, NDC 61786-0741-08 (Orig: 00548-9021-00), Ref: 33632, Rx only, Packaged by: RemedyRepack Inc, Indiana, PA 15704; Mfg by: Amphastar, Rancho Cucamonga, CA 91730.

by RemedyRePack Inc.

Reason
Crystallization: Product is being recalled due to the manufacturer's recall due to the presence of visible particulate in vials that has been identified as crystalline ketorolac calcium salt.
Recall initiated
August 22, 2017
Reported by FDA
October 4, 2017
Distribution
Product was distributed to one consignee in Louisiana.

View recall →

Drug Recall Terminated Historical recordClass I

Activase (alteplase), 100 mg (58 million IU), Lyophilized vial, packaged with 1 single-dose 100ml vial of sterile water for Injection USP and one transfer device. Manufactured by: Genentech, Inc. 1 DNA Way, South San Francisco, CA 84080-4990. NDC: 50242-0085-27

by Genentech, Inc.

Reason
Non-Sterility:presence of cracked or chipped glass at the neck of Sterile Water for Injection vials.
Recall initiated
September 5, 2017
Reported by FDA
September 27, 2017
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Aminocaproic Acid, USP (6-Aminohexanoic Acid) active pharmaceutical ingredient, packaged in a) 100 g jar (NDC 38779-0989-05, b) 1 kg jar (NDC 38779-0989-09), and 25 kg drum (NDC 38779-0989-07), Rx only, Packed by Medisca Inc., Plattsburgh, NY 12901, CAS: 60-32-1. 38779-0989-05; jar, 300 ml, white HDPE 38779-0989-07; drum, 15 gallon, Fiber 38779-0989-09; 2.8L, white, HDPE

by Medisca, Inc.

Reason
CGMP Deviations: Product manufactured for Industrial Use but was labeled and distributed for Pharmacy Compounding Use.
Recall initiated
September 14, 2017
Reported by FDA
September 27, 2017
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Procrit (epoetin alfa), 10,000 units/mL, packaged in a) box of 6 single use 1 mL vials (NDC 59676-310-01), b) box of 25 single use 1 mL vials (NDC 59676-310-02), Rx Only, Manufactured by: Amgen, Inc. Thousand Oaks, CA 91320, Manufactured for: Janssen Products, LP Horsham, PA 19044

by Amgen, Inc.

Reason
Presence of particulate matter: glass flakes identified as lamellae observed during a routine quality inspection.
Recall initiated
September 13, 2017
Reported by FDA
September 27, 2017
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Daytrana (methylphenidate transdermal system) Delivers 15 mg over 9 hours (1.6 mg/hr) Rx Only Contains: 30 Patches Manufactured for: Noven Therapeutics, LLC. Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC# 68968-5553-3

by Noven Pharmaceuticals, Inc.

Reason
Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.
Recall initiated
August 30, 2017
Reported by FDA
September 27, 2017
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Daytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours (3.3 mg/hr) Rx Only Contains: 30 Patches Manufactured for: Noven Therapeutics, LLC. Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC# 68968-5555-3

by Noven Pharmaceuticals, Inc.

Reason
Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.
Recall initiated
August 30, 2017
Reported by FDA
September 27, 2017
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Daytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours (2.2 mg/hr) Rx Only Contains: 30 Patches Manufactured for: Noven Therapeutics, LLC. Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC# 68968-5554-3

by Noven Pharmaceuticals, Inc.

Reason
Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.
Recall initiated
August 30, 2017
Reported by FDA
September 27, 2017
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Rx Only Contains: 30 Patches Manufactured for: Noven Therapeutics, LLC. Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC# 68968-5552-3

by Noven Pharmaceuticals, Inc.

Reason
Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.
Recall initiated
August 30, 2017
Reported by FDA
September 27, 2017
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Levophed (norepinephrine bitartrate) injection, USP, 4 mg/4 mL (1mg/mL), 4mL Fill in 5 mL Single dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3375-04

by Pfizer Inc.

Reason
Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.
Recall initiated
August 22, 2017
Reported by FDA
September 27, 2017
Distribution
United States Nationwide (including Puerto Rico) and Singapore

View recall →

Drug Recall Terminated Historical recordClass II

HYDROmorphone HCl Injection, USP, 2 mg/mL, 1mL Single-use vial, packaged in cartons of 25 vials, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3365-11 (carton) and 0409-3365-01(vial)

by Pfizer Inc.

Reason
Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.
Recall initiated
August 22, 2017
Reported by FDA
September 27, 2017
Distribution
United States Nationwide (including Puerto Rico) and Singapore

View recall →

Drug Recall Terminated Historical recordClass II

Fentanyl Citrate (Preservative Free) 20 mcg per mL (2,000 mcg per 100 mL) 100 mL total volume in a 100 mL LifeCare Bag in Sodium Chloride 0.9% Rx Only, Compounded by PharMEDium Services, LLC, Cleveland, MS 38732, NDC 61553-605-52

by PharMEDium Services, LLC

Reason
Labeling: Not Elsewhere Classified- Diluent used to compound product expired prior to the expiration date assigned to the compounded product.
Recall initiated
April 6, 2017
Reported by FDA
September 27, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Fentanyl Citrate (Preservative Free) 10 mcg per mL (1,000 mcg per 100 mL) 100 mL total volume in a 100 mL LifeCare Bag in Sodium Chloride 0.9% Rx Only, Compounded by PharMEDium Services, LLC, Cleveland, MS 38732, NDC 61553-112-52.

by PharMEDium Services, LLC

Reason
Labeling: Not Elsewhere Classified- Diluent used to compound product expired prior to the expiration date assigned to the compounded product.
Recall initiated
April 6, 2017
Reported by FDA
September 27, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Quillivant XR methylphenidate HCl, for extended-release oral suspension, 750mg/150 mL total volume (When constituted with 131 mL of water, 25 mg/5 mL (5 mg/mL) when reconstituted, Rx Only, Distributed by Nextwave Pharmaceuticals, Inc. A subsidiary of Pfizer Inc., New York, NY 10017, Manufactured by Tris Pharma, Inc., Monmouth Junction, NJ 08852, NDC 24478-200-25.

by Pfizer Inc.

Reason
Failed Dissolution Specifications
Recall initiated
August 4, 2017
Reported by FDA
September 27, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Quillivant XR methylphenidate HCl, for extended-release oral suspension, 600 mg/120 mL total volume (When constituted with 105 mL of water, 25 mg/5 mL (5 mg/mL) when reconstituted, Rx Only, Distributed by Nextwave Pharmaceuticals, Inc. A subsidiary of Pfizer Inc., New York, NY 10017, Manufactured by Tris Pharma, Inc., Monmouth Junction, NJ 08852, NDC 24478-200-20.

by Pfizer Inc.

Reason
Failed Dissolution Specifications
Recall initiated
August 4, 2017
Reported by FDA
September 27, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Phentermine, USP Capsules, 15 mg, 30 count bottles, Rx only, Packaged By: Aidarex Pharmaceuticals, Corona, CA, MFG: KVK-TECH INC. Newtown. PA --- 33261-0361-30

by Aidarex Pharmaceuticals LLC

Reason
Failed Impurities/Degradation Specification; out-of-specification results for individual unknown impurities at the 30 month Room Temperature Retained Sample stability test
Recall initiated
September 5, 2017
Reported by FDA
September 20, 2017
Distribution
Distributed to the state of CA and NV.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.